Vermillion to Present at the Canaccord Genuity 37th Annual Growth Conference on August 10th

AUSTIN, Texas, Aug. 1, 2017 /PRNewswire/ -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that Valerie Palmieri, President and Chief Executive Officer, will provide a corporate overview at the Canaccord Genuity 37^th Annual Growth Conference, being held August 9-10 in Boston, Massachusetts.

About Vermillion
Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with critical disease improve their overall health outcomes.

Investor Relations Contact:
Michael Wood
LifeSci Advisors LLC
646-597-6983
mwood@lifesciadvisors.com

View original content:http://www.prnewswire.com/news-releases/vermillion-to-present-at-the-canaccord-genuity-37th-annual-growth-conference-on-august-10th-300497614.html

SOURCE Vermillion, Inc.